Early research (Phase 1)Looking for participantsNCT06482905
What this trial is testing
Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
Who this might be right for
High-grade GliomaWHO Grade Ⅳ Glioma
Tcelltech Inc. 52